| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019743075 |
| P356 | DOI | 10.1038/SJ.GT.3302532 |
| P698 | PubMed publication ID | 15829992 |
| P5875 | ResearchGate publication ID | 7907082 |
| P2093 | author name string | Chen S | |
| Yang B | |||
| Ding J | |||
| Grayburn PA | |||
| Shohet RV | |||
| Korpanty G | |||
| Frenkel PA | |||
| P2860 | cites work | Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial | Q73142282 |
| Angiogenesis in ischemic human myocardium: clinical results after 3 years | Q73957780 | ||
| Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein | Q74390750 | ||
| Effect of gas-containing microspheres and echo contrast agents on free radical formation by ultrasound | Q77313339 | ||
| Reparable sonoporation generated by microstreaming | Q77874727 | ||
| Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia | Q78019724 | ||
| Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization | Q28578396 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound | Q30309923 | ||
| Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and its Local Effects on Tissue | Q30472481 | ||
| Delivery of Colloidal Particles and Red Blood Cells to Tissue Through Microvessel Ruptures Created by Targeted Microbubble Destruction With Ultrasound | Q30472604 | ||
| Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis | Q31882403 | ||
| Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary | Q33917476 | ||
| Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy | Q34086442 | ||
| Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials | Q34134567 | ||
| Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia | Q34196366 | ||
| Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis | Q34960144 | ||
| Arteriogenesis: the development and growth of collateral arteries | Q35074935 | ||
| Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries | Q35587460 | ||
| Therapeutic angiogenesis in cardiovascular disease | Q35605439 | ||
| Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines | Q35789807 | ||
| Genetic analysis of blood vessel formation role of endothelial versus smooth muscle cells | Q37828670 | ||
| Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial | Q38522489 | ||
| Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial | Q38523342 | ||
| Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris | Q40586433 | ||
| Artificial Cavitation Nuclei Significantly Enhance Acoustically Induced Cell Transfection | Q41028344 | ||
| Angiogenesis in ischemic heart disease | Q41338703 | ||
| Improved DNA: liposome complexes for increased systemic delivery and gene expression | Q41633695 | ||
| Bioeffects of myocardial contrast microbubble destruction by echocardiography | Q44160553 | ||
| Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis | Q44945389 | ||
| Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. | Q45862896 | ||
| Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart | Q45864640 | ||
| VEGF-mediated inflammation precedes angiogenesis in adult brain | Q47601994 | ||
| Effects of ultrasound-targeted microbubble destruction on cardiac gene expression | Q47664558 | ||
| The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine | Q50252742 | ||
| Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia | Q59703772 | ||
| Vascular Endothelial Growth Factor-Induced Migration of Vascular Smooth Muscle Cells in Vitro | Q62698773 | ||
| Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction | Q64377523 | ||
| Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium | Q64380732 | ||
| Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease | Q73030654 | ||
| The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis | Q73139585 | ||
| P433 | issue | 17 | |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 1305-1312 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles | |
| P478 | volume | 12 |
| Q30476094 | A Temporal Study of Ultrasound Contrast Agent-Induced Changes in Capillary Density |
| Q54297117 | A new method of ultrasonic nonviral gene delivery to the adult myocardium |
| Q30461828 | Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter |
| Q30482463 | Acoustic response of compliable microvessels containing ultrasound contrast agents. |
| Q30458491 | Advances in Ultrasound Mediated Gene Therapy Using Microbubble Contrast Agents |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q35151455 | Biodistribution of P-selectin targeted microbubbles |
| Q37194005 | Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. |
| Q51118895 | Characterisation of Liposome-Loaded Microbubble Populations for Subharmonic Imaging |
| Q37871463 | Contrast Ultrasound and Targeted Microbubbles: Diagnostic and Therapeutic Applications for Angiogenesis |
| Q38051855 | Contrast Ultrasound and Targeted Microbubbles: Diagnostic and Therapeutic Applications in Progressive Diabetic Nephropathy |
| Q30459198 | Controlled permeation of cell membrane by single bubble acoustic cavitation |
| Q30444363 | Delivery of adiponectin gene to skeletal muscle using ultrasound targeted microbubbles improves insulin sensitivity and whole body glucose homeostasis |
| Q30410837 | Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery. |
| Q103825412 | Downregulation of GSK-3β Expression via Ultrasound-Targeted Microbubble Destruction Enhances Atherosclerotic Plaque Stability in New Zealand Rabbits |
| Q30485366 | Dynamic microPET imaging of ultrasound contrast agents and lipid delivery |
| Q36559164 | Echocardiography: prospects for the next 5 years |
| Q30444014 | Efficient Microbubble- and Ultrasound-Mediated Plasmid DNA Delivery into a Specific Rat Liver Lobe via a Targeted Injection and Acoustic Exposure Using a Novel Ultrasound System |
| Q44098018 | Efficient gene delivery to myocardium with ultrasound targeted microbubble destruction and polyethylenimine |
| Q30502097 | Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology |
| Q30404535 | Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver |
| Q36752679 | Gene therapy progress and prospects: ultrasound for gene transfer |
| Q36811199 | Imaging of angiogenesis in cardiology |
| Q44927479 | Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents |
| Q37245245 | In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver |
| Q37837837 | In vivo small animal imaging: Current status and future prospects |
| Q45854891 | Influence of DNA-Microbubble Coupling on Contrast Ultrasound-Mediated Gene Transfection in Muscle and Liver. |
| Q30453566 | Kidney-Targeted Transplantation of Mesenchymal Stem Cells by Ultrasound-Targeted Microbubble Destruction Promotes Kidney Repair in Diabetic Nephropathy Rats |
| Q30459779 | Leveraging the power of ultrasound for therapeutic design and optimization |
| Q30370773 | Localized in vivo model drug delivery with intravascular ultrasound and microbubbles. |
| Q30417239 | Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles |
| Q38785743 | Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy. |
| Q38028448 | Nonviral gene therapy targeting cardiovascular system |
| Q30384749 | Nucleic acid delivery with microbubbles and ultrasound. |
| Q50489892 | Optimization of transfection parameters for ultrasound/SonoVue microbubble-mediated hAng-1 gene delivery in vitro |
| Q50855923 | Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells. |
| Q98159116 | Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake in vivo |
| Q38803772 | Prospect of ultrasound-mediated gene delivery in cardiovascular applications |
| Q30475028 | Protein Expression of Mesenchymal Stem Cells after Transfection of pcDNA3.1−‐hVEGF165 by Ultrasound‐Targeted Microbubble Destruction |
| Q53278662 | Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair |
| Q30455582 | Spatiotemporally controlled single cell sonoporation |
| Q30409234 | State-of-the-art materials for ultrasound-triggered drug delivery |
| Q34476907 | Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery |
| Q64380083 | Study on the Multidrug Resistance 1 Gene Transfection Efficiency Using Adenovirus Vector Enhanced by Ultrasonic Microbubbles In Vitro |
| Q36158355 | Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles |
| Q30438396 | Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis |
| Q30472688 | Targeted renal therapies through microbubbles and ultrasound☆ |
| Q85407218 | The Increase of VEGF Secretion From Endothelial Progenitor Cells Post Ultrasonic VEGF Gene Delivery Enhances the Proliferation and Migration of Endothelial Cells |
| Q30457884 | The angiogenic response is dependent on ultrasound contrast agent concentration |
| Q30278047 | The partitioning of nanoparticles to endothelium or interstitium during ultrasound-microbubble-targeted delivery depends on peak-negative pressure |
| Q39476525 | The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro |
| Q58698613 | The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction |
| Q45306316 | Therapeutic effects of paclitaxel-containing ultrasound contrast agents |
| Q45878127 | Transfection efficiency of TDL compound in HUVEC enhanced by ultrasound-targeted microbubble destruction |
| Q42247709 | Ultrasound and microbubble-targeted delivery of small interfering RNA into primary endothelial cells is more effective than delivery of plasmid DNA. |
| Q45872837 | Ultrasound- and liposome microbubble-mediated targeted gene transfer to cardiomyocytes in vivo accompanied by polyethylenimine. |
| Q52817287 | Ultrasound-Targeted Microbubble Destruction for Cardiac Gene Delivery |
| Q36640312 | Ultrasound-induced cavitation: applications in drug and gene delivery |
| Q80162439 | [Sonopermeabilization: therapeutic alternative with ultrasound and microbubbles] |
| Q39413020 | miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling |
Search more.